Acquisition is expected to strengthens Thermo Fisher’s position in delivering clinical information to pharma and biotech ...
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback